During the past decade, Instituto de Olhos de Goiania conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Olhos de Goiania" are "Myopic Choroidal Neovascularization" (2 trials), "Acute Conjunctivitis" (1 trials), "Age Related Macular Degeneration" (1 trials), "Astigmatism" (1 trials) and "Choroidal Retinal Neovascularization" (1 trials). Many other conditions were trialed in "Instituto de Olhos de Goiania" in a lesser frequency.

Most popular intervention types in "Instituto de Olhos de Goiania" are "Drug" (7 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "INTRASTROMAL CORNEAL RING SEGMENT" (2 trials), "Aflibercept" (1 trials), "Aflibercept Injection" (1 trials), "Bevacizumab" (1 trials) and "Bevacizumab (Intravitreal injection)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Olhos de Goiania" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Olhos de Goiania". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Instituto de Olhos de Goiania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Olhos de Goiania, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".